Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Information source: Santa Casa de Misericordia de Santos
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pain
Intervention: Nevanac (Drug); Acular LS (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Santa Casa de Misericordia de Santos Official(s) and/or principal investigator(s): Gustavo T Grottone, MD, MBA,MSc, Principal Investigator, Affiliation: SCMS João C Grottone, MD, MBA, Study Chair, Affiliation: SCMS
Overall contact: Gustavo T Grottone, MD, MBA, MSc, Phone: 551381515130, Email: gtg2001@terra.com.br
Summary
Different case reports are showing that depending on the drug used for eye drops, it might
provoke a painful sensation. Actually two leading NSAIDs are used in ophthalmology. This
study is intended to provide information about this parameter concerning these two drugs.
Clinical Details
Official title: Phase 4 Study of Topical NSAID for Ophthalmologic Use: Pain Measurement After First Drop.
Study design: Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Primary outcome: Pain after instilation
Eligibility
Minimum age: 21 Years.
Maximum age: 80 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patient over 21 years old
- No ocular surface pathology
- Eligible for cataract surgery
Exclusion Criteria:
- Any other eye pathology other than cataract
Locations and Contacts
Gustavo T Grottone, MD, MBA, MSc, Phone: 551381515130, Email: gtg2001@terra.com.br
Santa Casa de Misericordia de Santos, Santos, Sao Paulo 11055360, Brazil; Recruiting Gustavo T Grottone, MD, MBA, MSc, Phone: 551381515130, Email: gtg2001@terra.com.br Gustavo T Grottone, MD, MBA, Principal Investigator
Additional Information
Starting date: March 2009
Last updated: March 25, 2009
|